Department of Obstetrics and Gynecology, University Hospital Jerez de La Frontera, Hospital Quirónsalud Campo de Gibraltar, Faculty of Medicine, University of Cádiz, Cádiz, Spain.
Department of Obstetrics and Gynecology, Hospital Punta de Europa, Algeciras, Cádiz, Spain.
Sci Rep. 2021 Jan 21;11(1):1872. doi: 10.1038/s41598-021-81436-9.
The objective of this study was to investigate whether the BC tumor biology in women with larger breast volume, in obese women and especially in women with central adiposity at the moment of diagnosis of BC is more aggressive than in those women without these characteristics. 347 pre- and postmenopausal women with a recent diagnosis of BC were analyzed. In all patients, anthropometric measurements at the time of diagnosis was collected. In 103 of them, the breast volume was measured by the Archimedes method. The Breast volume, BMI, WHR and the menopausal status were related to different well-known pathological prognostic factors for BC. At the time of diagnosis, 35.4% were obese (BMI > 30 kg/m), 60.2% had a WHR ≥ 0.85, 68.8% were postmenopausal and 44.7% had a breast volume considered "large" (> 600 cc). Between patients with a large breast volume, only a higher prevalence of ER (+) tumors was found (95.3% vs. 77.2%; p = 0.04) compared to those with small breast volumes. The obese BC patients showed significantly higher rates of large tumors (45.5% vs. 40.6%; p = 0.04), axillary invasion (53.6% vs. 38.8%; p = 0.04), undifferentiated tumors (38.2% vs. 23.2%) and unfavorable NPI (p = 0.04) than non-obese women. Those with WHR ≥ 0.85 presented higher postsurgical tumor stages (61.7% vs. 57.8%; p = 0.03), higher axillary invasion (39.9% vs. 36.0%; p = 0.004), more undifferentiated tumors (30.0% vs. 22.3%; p = 0.009), higher lymphovascular infiltration (6.5% vs. 1.6%; p = 0.02), and a higher NPI (3.6 ± 1.8 vs. 3.2 ± 1.8; p = 0.04). No statistically significant differences were found according to menopausal status. We conclude that obesity, but especially central obesity can be associated with a more aggressive tumour phenotype. No relation between breast volume and tumoral prognostic factors was found, except for a higher proportion of ER (+) tumor in women with higher breast volume.
这项研究的目的是探讨在乳房体积较大的女性、肥胖女性、尤其是在诊断乳腺癌时存在中央肥胖的女性中,BC 肿瘤生物学是否比没有这些特征的女性更具侵袭性。分析了 347 名近期诊断为乳腺癌的绝经前和绝经后妇女。在所有患者中,均采集了诊断时的人体测量学测量值。其中 103 例采用阿基米德法测量乳房体积。乳房体积、BMI、腰臀比和绝经状态与乳腺癌的不同已知病理预后因素有关。在诊断时,35.4%为肥胖(BMI>30kg/m),60.2%为腰臀比≥0.85,68.8%为绝经后,44.7%的乳房体积被认为“大”(>600cc)。在乳房体积较大的患者中,仅发现 ER(+)肿瘤的患病率较高(95.3%比 77.2%;p=0.04),而乳房体积较小的患者则较低。肥胖的乳腺癌患者的大肿瘤(45.5%比 40.6%;p=0.04)、腋窝侵犯(53.6%比 38.8%;p=0.04)、未分化肿瘤(38.2%比 23.2%)和不良的 NPI(p=0.04)发生率明显高于非肥胖女性。腰臀比≥0.85的患者术后肿瘤分期更高(61.7%比 57.8%;p=0.03),腋窝侵犯(39.9%比 36.0%;p=0.004)、未分化肿瘤(30.0%比 22.3%;p=0.009)、淋巴管血管浸润(6.5%比 1.6%;p=0.02)和 NPI 更高(3.6±1.8 比 3.2±1.8;p=0.04)。根据绝经状态,未发现统计学上的显著差异。我们的结论是,肥胖,尤其是中央肥胖可能与侵袭性更强的肿瘤表型相关。除了乳房体积较大的女性中 ER(+)肿瘤的比例较高外,乳房体积与肿瘤预后因素之间没有发现关系。